THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING
Around the Region

Autism test maker secures $9m

Globe Staff / June 2, 2010

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

  • E-mail|
  • Print|
  • Reprints|
  • |
Text size +

SynapDx Corp., a new Waltham company that aims to develop tests for the early detection of autism, yesterday announced the completion of a $9 million round of financing.

Investing were Bain Capital Ventures, General Catalyst Partners, and North Bridge Venture Partners.

“Autism has a profound effect on children and their families,’’ chief executive Stanley N. Lapidus said in a news release. “The right objective blood-based diagnostic test for autism may help achieve earlier diagnosis, more rapid intervention, and improved outcomes.”